81 participants
Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2018-05-16
- Start Date:
- 2008-06-30
- Completion:
- 2016-05-31
Conditions
- Chronic Myelogenous Leukemia
- Hematologic Malignancies
Interventions
- DRUG
No Results Yet